These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

70 related items for PubMed ID: 3110477

  • 1. Modulation of cell proliferation by human recombinant interleukin-1 and immune interferon.
    Tsai SC, Gaffney EV.
    J Natl Cancer Inst; 1987 Jul; 79(1):77-81. PubMed ID: 3110477
    [Abstract] [Full Text] [Related]

  • 2. Heterogeneous response of human colon cancer cells to the cytostatic and cytotoxic effects of recombinant human cytokines: interferon-alpha, interferon-gamma, tumor necrosis factor, and interleukin-1.
    Morikawa K, Fidler IJ.
    J Biol Response Mod; 1989 Apr; 8(2):206-18. PubMed ID: 2499665
    [Abstract] [Full Text] [Related]

  • 3. Growth inhibition of a human colorectal carcinoma cell line by interleukin 1 is associated with enhanced expression of gamma-interferon receptors.
    Raitano AB, Korc M.
    Cancer Res; 1993 Feb 01; 53(3):636-40. PubMed ID: 8425199
    [Abstract] [Full Text] [Related]

  • 4. Lymphocyte-activating and growth-inhibitory activities for several sources of native and recombinant interleukin 1.
    Gaffney EV, Tsai SC.
    Cancer Res; 1986 Aug 01; 46(8):3834-7. PubMed ID: 3488121
    [Abstract] [Full Text] [Related]

  • 5. Effects of human recombinant alpha 2 arg-interferon and gamma-interferon on human breast cancer cell lines: dissociation of antiproliferative activity and induction of HLA-DR antigen expression.
    Gastl G, Marth C, Leiter E, Gattringer C, Mayer I, Daxenbichler G, Flener R, Huber C.
    Cancer Res; 1985 Jul 01; 45(7):2957-61. PubMed ID: 3924395
    [Abstract] [Full Text] [Related]

  • 6. Synergistic interactions of interleukin 1, interferon-beta, and tumor necrosis factor in terminally differentiating a mouse myeloid leukemic cell line (M1). Evidence that interferon-beta is an autocrine differentiating factor.
    Onozaki K, Urawa H, Tamatani T, Iwamura Y, Hashimoto T, Baba T, Suzuki H, Yamada M, Yamamoto S, Oppenheim JJ.
    J Immunol; 1988 Jan 01; 140(1):112-9. PubMed ID: 3275716
    [Abstract] [Full Text] [Related]

  • 7. Overlapping polypeptide induction in human fibroblasts in response to treatment with interferon-alpha, interferon-gamma, interleukin 1 alpha, interleukin 1 beta, and tumor necrosis factor.
    Beresini MH, Lempert MJ, Epstein LB.
    J Immunol; 1988 Jan 15; 140(2):485-93. PubMed ID: 3121746
    [Abstract] [Full Text] [Related]

  • 8. Human interleukin 1 is a cytocidal factor for several tumor cell lines.
    Onozaki K, Matsushima K, Aggarwal BB, Oppenheim JJ.
    J Immunol; 1985 Dec 15; 135(6):3962-8. PubMed ID: 2415593
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The role of p21 in interferon gamma-mediated growth inhibition of human breast cancer cells.
    Gooch JL, Herrera RE, Yee D.
    Cell Growth Differ; 2000 Jun 15; 11(6):335-42. PubMed ID: 10910100
    [Abstract] [Full Text] [Related]

  • 11. Differential gamma-interferon response of human colon carcinoma cells: inhibition of proliferation and modulation of immunogenicity as independent effects of gamma-interferon on tumor cell growth.
    Pfizenmaier K, Bartsch H, Scheurich P, Seliger B, Ucer U, Vehmeyer K, Nagel GA.
    Cancer Res; 1985 Aug 15; 45(8):3503-9. PubMed ID: 3160456
    [Abstract] [Full Text] [Related]

  • 12. Retinoic acid induces expression of the interleukin-1beta gene in cultured normal human mammary epithelial cells and in human breast carcinoma lines.
    Liu L, Gudas LJ.
    J Cell Physiol; 2002 Nov 15; 193(2):244-52. PubMed ID: 12385002
    [Abstract] [Full Text] [Related]

  • 13. Induction of hepatocyte growth factor/scatter factor by interferon-gamma in human leukemia cells.
    Gohda E, Takebe T, Sotani T, Nakamura S, Minowada J, Yamamoto I.
    J Cell Physiol; 1998 Jan 15; 174(1):107-14. PubMed ID: 9397161
    [Abstract] [Full Text] [Related]

  • 14. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
    Freedman RS, Kudelka AP, Kavanagh JJ, Verschraegen C, Edwards CL, Nash M, Levy L, Atkinson EN, Zhang HZ, Melichar B, Patenia R, Templin S, Scott W, Platsoucas CD.
    Clin Cancer Res; 2000 Jun 15; 6(6):2268-78. PubMed ID: 10873077
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of hepatocyte growth factor induction in human dermal fibroblasts by interleukin-1 and its prevention by interferon-gamma.
    Takami Y, Kanasaki K, Tsubouchi H, Ishii T, Yamamoto I, Gohda E.
    Biochem Biophys Res Commun; 2004 Dec 17; 325(3):676-82. PubMed ID: 15541342
    [Abstract] [Full Text] [Related]

  • 16. Correlation between human cell growth response to interleukin 1 and receptor binding.
    Gaffney EV, Koch G, Tsai SC, Loucks T, Lingenfelter SE.
    Cancer Res; 1988 Oct 01; 48(19):5455-9. PubMed ID: 2970890
    [Abstract] [Full Text] [Related]

  • 17. Antitumor actions of interferon-gamma and interleukin-1 beta on human papillary thyroid carcinoma cell lines.
    Yip I, Pang XP, Berg L, Hershman JM.
    J Clin Endocrinol Metab; 1995 May 01; 80(5):1664-9. PubMed ID: 7745015
    [Abstract] [Full Text] [Related]

  • 18. Accessory function of human fibroblasts in mitogen-stimulated interferon-gamma production by T lymphocytes. Inhibition by interleukin 1 and tumor necrosis factor.
    Le JM, Vilcek J.
    J Immunol; 1987 Nov 15; 139(10):3330-7. PubMed ID: 3119705
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.